Related Experiment Videos
Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis
A G Fam1, B Perez-Ordonez, K Imrie
1Department of Medicine, Sunnybrook Health Science Centre, University of Toronto, Ontario, Canada. kathy.carey@swchsc.on.ca
Abstract:
A patient with rheumatoid arthritis developed a reversible, primary cutaneous, large B cell lymphoma during prolonged methotrexate (MTX) treatment. Regression of the skin lesions after discontinuation of the drug suggested a close relationship to MTX. Increased clinical awareness, discontinuation of MTX, and close observation are important in the initial management of this rare lymphoproliferative disorder.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...